Lokhorst HM - Search Results

1

Risk factors for hematological malignancy in polyneuropathy associated with monoclonal gammopathy.

Eurelings M, Notermans NC, Van de Donk NW, Lokhorst HM. Eurelings M, et al. Among authors: lokhorst hm. Muscle Nerve. 2001 Oct;24(10):1295-302. doi: 10.1002/mus.1147. Muscle Nerve. 2001. PMID: 11562908

2

Immunoglobulin gene analysis in polyneuropathy associated with IgM monoclonal gammopathy.

Eurelings M, Notermans NC, Lokhorst HM, van Kessel B, Jacobs BC, Wokke JH, Sahota SS, Bloem AC. Eurelings M, et al. Among authors: lokhorst hm. J Neuroimmunol. 2006 Jun;175(1-2):152-9. doi: 10.1016/j.jneuroim.2006.02.008. Epub 2006 Mar 6. J Neuroimmunol. 2006. PMID: 16600385

3

Cytogenetic aberrations in neuropathy associated with IgM monoclonal gammopathy.

Eurelings M, Lokhorst HM, Notermans NC, Krijtenburg PJ, Kessel Bv, Eleveld MJ, Bloem A, Wokke JH, Poot M, Buijs A. Eurelings M, et al. Among authors: lokhorst hm. J Neurol Sci. 2007 Sep 15;260(1-2):124-31. doi: 10.1016/j.jns.2007.04.022. Epub 2007 Jun 1. J Neurol Sci. 2007. PMID: 17543994

4

Three families with polyneuropathy associated with monoclonal gammopathy.

Manschot SM, Notermans NC, van den Berg LH, Verschuuren JJ, Lokhorst HM. Manschot SM, et al. Among authors: lokhorst hm. Arch Neurol. 2000 May;57(5):740-2. doi: 10.1001/archneur.57.5.740. Arch Neurol. 2000. PMID: 10815142

5

Malignant transformation in polyneuropathy associated with monoclonal gammopathy.

Eurelings M, Lokhorst HM, Kalmijn S, Wokke JH, Notermans NC. Eurelings M, et al. Among authors: lokhorst hm. Neurology. 2005 Jun 28;64(12):2079-84. doi: 10.1212/01.WNL.0000176296.79088.9A. Neurology. 2005. PMID: 15985576

6

Intermittent cyclophosphamide with prednisone versus placebo for polyneuropathy with IgM monoclonal gammopathy.

Niermeijer JM, Eurelings M, van der Linden MW, Lokhorst HM, Franssen H, Fischer K, Teunissen LL, van den Berg LH, Schobben F, Wokke JH, Notermans NC. Niermeijer JM, et al. Among authors: lokhorst hm. Neurology. 2007 Jul 3;69(1):50-9. doi: 10.1212/01.wnl.0000265055.28218.cc. Neurology. 2007. PMID: 17606880 Clinical Trial.

7

Effect of stem cell transplantation for B-cell malignancies on disease course of associated polyneuropathy.

Stork AC, van der Pol WL, van Kessel D, Lokhorst HM, Notermans NC. Stork AC, et al. Among authors: lokhorst hm. J Neurol. 2012 Oct;259(10):2100-4. doi: 10.1007/s00415-012-6463-0. Epub 2012 Mar 8. J Neurol. 2012. PMID: 22399147 Free PMC article.

8

Intermittent cyclophosphamide and prednisone treatment of polyneuropathy associated with monoclonal gammopathy of undetermined significance.

Notermans NC, Lokhorst HM, Franssen H, Van der Graaf Y, Teunissen LL, Jennekens FG, Van den Berg LH, Wokke JH. Notermans NC, et al. Among authors: lokhorst hm. Neurology. 1996 Nov;47(5):1227-33. doi: 10.1212/wnl.47.5.1227. Neurology. 1996. PMID: 8909434 Clinical Trial.

9

Secondary monoclonal gammopathy of undetermined significance after allogeneic stem cell transplantation in multiple myeloma.

Schmitz MF, Otten HG, Franssen LE, van Dorp S, Strooisma T, Lokhorst HM, van de Donk NW. Schmitz MF, et al. Among authors: lokhorst hm. Haematologica. 2014 Dec;99(12):1846-53. doi: 10.3324/haematol.2014.111104. Epub 2014 Sep 5. Haematologica. 2014. PMID: 25193963 Free PMC article. Clinical Trial.

10

G3139, a Bcl-2 antisense oligodeoxynucleotide, induces clinical responses in VAD refractory myeloma.

van de Donk NW, de Weerdt O, Veth G, Eurelings M, van Stralen E, Frankel SR, Hagenbeek A, Bloem AC, Lokhorst HM. van de Donk NW, et al. Among authors: lokhorst hm. Leukemia. 2004 Jun;18(6):1078-84. doi: 10.1038/sj.leu.2403363. Leukemia. 2004. PMID: 15085157 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

244 results

Search Page

Filters